Device type17-Hydroxyprogesterone IVD, kit, chemiluminescent immunoassay: A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of 17-hydroxyprogesterone in a clinical specimen, using a chemiluminescent immunoassay method.
FDA categoryRadioimmunoassay, 17-Hydroxyprogesterone
Device ID00840239014290
Catalog numberEIA-1429
AvailabilityPrescription
Single useYes
MRI safetyLabeling does not contain MRI Safety Information